1. Home
  2. CDNA

CDNA

CareDx Inc.

Logo CareDx Inc.

Health Care

Medical Specialities

Nasdaq

as 04-19-2024 3:32pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Founded: N/A Country:
United States
United States
Employees: N/A City: BRISBANE
Market Cap: 493.4M IPO Year: 2014
Target Price: $13.50 AVG Volume (30 days): 908.4K
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.54 EPS Growth: N/A
52 Week Low/High: $4.80 - $12.93 Next Earning Date: 05-08-2024
Revenue: $280,324,000 Revenue Growth: -12.89%
Revenue Growth (this year): -2.99% Revenue Growth (next year): 7.03%

Share on Social Networks: